Lors de ce cours de deux semaines, des experts scientifiques de l'OEDT, des professeurs de l'ISCTE et des responsables politiques prépareront les participants à répondre aux défis complexes relatifs à la politique des drogues en Europe et au delà. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

____________________________________________________________________________

The Lisbon-based Instituto Superior das Ciências do Trabalho e da Empresa (ISCTE) and the EU drugs agency (EMCDDA) are currently collaborating on a summer school programme entitled: ‘Illicit drugs in Europe: supply, demand and public policies’. Registration opens today for the course which will take place in Lisbon from 2–13 July 2012.

During the two-week course, EMCDDA scientific experts, ISCTE-professors and policymakers, will prepare participants to meet the complex policy challenges in this field, by providing a multi-disciplinary and inclusive approach to the study of the drug problem, both in Europe and beyond.

Week 1 of the summer school focuses on ‘Defining the problems’ and will feature lectures on ‘Problem drug use in Europe’, ‘Drug supply in Europe’ and ‘Detecting new drugs’.

Week 2 explores ‘Understanding drug policies and interventions’ with lectures on ‘(Inter)national drug policies’, ‘Preventing drug use’ and ‘Harm reduction’ and ‘Prison health’.

The target audiences for the summer school are university students (undergraduate and graduate), researchers, professionals and administrators interested or working in the drugs field.

ECTS credits will be given for the courses and students can transfer credits to other European universities using the ECTS-system.

Further information on the summer school programme, fees and location is available on the website.  

Registration

First phase: 15 December–15 March (discount for registration in this phase)

Second phase: 15 March–15 June

Limit: 50 participants

Applicants must send a completed application form, a CV and a proof of payment of the inscription fees to this address.  

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.